Two examples of FDA-approved intracameral implants are Durysta (Allergan) and iDoseTR (Glaukos), both of which provide ...

NHS England has published updated medical retinal treatment pathway recommendations for wet age-related macular degeneration (wAMD), with pathways for diabetic macular oedema (DMO) and retinal vein ...

Kingston optician Eyecare Opticians (020 8549 0331) updates its eye exams with AI-enhanced OCT scanning that detects wet ...

Belite Bio has completed enrolment in the 24-month PHOENIX Phase III trial assessing the tolerability and safety of oral ...

A new study identifies how the molecule, called ApoM, can clear harmful cholesterol deposits linked to macular degeneration ...

Aldeyra's Reproxalap progresses towards FDA approval, with a potential $100M AbbVie deal. There’s still upside potential, ...

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

The program allows patients to undergo genetic testing and high-resolution retinal imaging anonymously and provide insights ...

The PHOENIX study is a 24-month, randomized, double-masked, placebo-controlled, multicenter, pivotal Phase 3 trial. The study is ongoing across sites in the United States, the United Kingdom, France, ...

Yesafili is a VEGF inhibitor indicated for the treatment of neovascular (wet) age-related macular degeneration (AMD), ...

In this Healio Video Perspective from Clinical Trials at the Summit, Arshad M. Khanani, MD, MA, FASRS, highlights first-time ...

Career focused on driving business growth and developing an integrated commercial strategy to deliver results ...